Finance

Lists
8NN:FRA
Thor Medical ASA
€0.50
-3.85%
(-0.020) 1D
Sep 3, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 8NN...
Open
€0.51
High
€0.51
Low
€0.50
Avg. vol.
1.00
Volume
3.00K
52-wk high
€0.65
52-wk low
€0.27
No. of employees
18
Open
€0.51
High
€0.51
Low
€0.50
Avg. vol.
1.00
Volume
3.00K
52-wk high
€0.65
52-wk low
€0.27
No. of employees
18
About Thor Medical ASA
CEOErik Skullerud
Employees18
Founded2009
Headquarters-
SectorBiotechnology
Previous reportsAll values in NOK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in NOK
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
369.50K
369.50K
450.00K
450.00K
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8.28M
8.28M
10.65M
10.65M
Operating expense
18.60M
18.60M
23.65M
23.65M
Total operating expenses
18.60M
18.60M
23.65M
23.65M
Operating income
-18.23M
-18.23M
-23.20M
-23.20M
Other non operating income
500.00
500.00
150.00K
150.00K
EBT including unusual items
-15.23M
-15.23M
-28.40M
-28.40M
EBT excluding unusual items
-15.23M
-15.23M
-28.40M
-28.40M
Income tax expense
-1.08M
-1.08M
-1.05M
-1.05M
Effective tax rate
7.08%
7.08%
3.70%
3.70%
Other operating expenses
4.96M
4.96M
6.30M
6.30M
Net income
-14.16M
-14.16M
-27.35M
-27.35M
Net profit margin
-3,831.12%
-3,831.12%
-6,077.78%
-6,077.78%
Earnings per share
-
-
-
-
Interest and investment income
3.11M
3.11M
-
-
Interest expense
-201.00K
-201.00K
-4.65M
-4.65M
Net interest expenses
2.91M
2.91M
-4.65M
-4.65M
Depreciation and amortization charges
5.36M
5.36M
6.70M
6.70M
EBITDA
-13.57M
-13.57M
-16.50M
-16.50M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google apps